Article Details

Biopharmaceutical Stock Flat Despite Upgrade to "Buy"

Retrieved on: 2021-04-13 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Biopharmaceutical Stock Flat Despite Upgrade to "Buy". View article details on hiswai:

Excerpt

The shares of biopharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are up 0.6% at $63.07 in pre-market trading, after Truist Securities ...

Article found on: www.schaeffersresearch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo